Xinchu Xiang

Title: Innovations of Xinchu Xiang in Hepatitis B Research

Introduction

Xinchu Xiang is a notable inventor based in Xiamen, China. He has made significant contributions to the field of medical research, particularly in the development of antibodies for the treatment of hepatitis B virus (HBV) infections. His work has the potential to impact the lives of many individuals affected by this disease.

Latest Patents

Xinchu Xiang holds a patent for an "Anti-hepatitis B virus antibody and uses thereof." This patent discloses antibodies targeting the hepatitis B surface antigen (HBsAg), especially humanized antibodies. The invention includes nucleic acid molecules encoding these antibodies, methods for their preparation, and pharmaceutical compositions containing them. The antibodies exhibit higher affinity for HBsAg at neutral pH compared to acidic pH, which significantly enhances virus clearance efficiency and prolongs the inhibition time of the virus. These antibodies can be utilized for preventing and treating HBV infections and related diseases, neutralizing HBV virulence, reducing serum levels of HBV DNA and HBsAg, and activating the humoral immune response in chronic HBV patients.

Career Highlights

Xinchu Xiang has worked with esteemed institutions such as Xiamen University and Yang Sheng Tang Company Limited. His research and innovations have positioned him as a key figure in the fight against hepatitis B.

Collaborations

Xinchu Xiang has collaborated with notable colleagues, including Wenxin Luo and Can Wen. Their combined efforts have contributed to advancements in the understanding and treatment of HBV.

Conclusion

Xinchu Xiang's innovative work in developing antibodies for hepatitis B represents a significant advancement in medical research. His contributions have the potential to improve treatment options for those affected by HBV, showcasing the importance of innovation in healthcare.